Finoriq research workspace
Aardvark Therapeutics, Inc. (AARD) News
Read recent company news headlines and source links for Aardvark Therapeutics, Inc. (AARD).
Company Snapshot
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
- Company
- Aardvark Therapeutics, Inc. (AARD)
- Ticker
- AARD
- Market Cap
- $120.9M
- Latest Price
- $5.525
- Industry
- Biotech & Pharma
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.